e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The prevalence of diagnosed ?1-antitrypsin deficiency and its comorbidities: results from a large population-based database
Timm Greulich, Christoph Nell, David Hohmann, Marco Grebe, Sabina Janciauskiene, Andreas Rembert Koczulla, Claus Franz Vogelmeier
Source:
Eur Respir J 2017; 49(1): 1600154; DOI: 10.1183/13993003.00154-2016
Journal Issue:
January
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Timm Greulich, Christoph Nell, David Hohmann, Marco Grebe, Sabina Janciauskiene, Andreas Rembert Koczulla, Claus Franz Vogelmeier. The prevalence of diagnosed ?1-antitrypsin deficiency and its comorbidities: results from a large population-based database. Eur Respir J 2017; 49(1): 1600154; DOI: 10.1183/13993003.00154-2016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study
Source: ERJ Open Res, 7 (1) 00754-2020; 10.1183/23120541.00754-2020
Year: 2021
What makes Alpha1-antitrypsin deficiency patients exacerbate: a 5-year cohort
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021
The prevalence and impact of autoantibodies among people with bronchiectasis: a data analysis of the EMBARC registry
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021
Baseline characteristics of patients enrolled in the EARCO prospective registry of alpha-1 antitrypsin deficiency: preliminary results.
Source: Virtual Congress 2021 – Treatments for airway diseases
Year: 2021
Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020
Alpha1-antitrypsin deficiency: An analysis of patient subgroups of the German registry
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
The effect of sex and age on the comorbidity burden of OSA: an observational analysis from a large nationwide US health claims database
Source: Eur Respir J 2016; 47: 1162-1169
Year: 2016
Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015
Prevalence of severe asthma – results from a population-based study.
Source: International Congress 2019 – Asthma and the world
Year: 2019
Incidence of alpha-1-antitrypsin (α1-AT) deficiency in patients with COPD in Poland, preliminary report
Source: Eur Respir J 2005; 26: Suppl. 49, 440s
Year: 2005
The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population – Results from the ongoing newborn screening
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Prevalence and factors associated with diabetes mellitus among tuberculosis patients: a nationwide cohort
Source: Eur Respir J 2016; 48: 264-268
Year: 2016
Excess economic burden of comorbidities in COPD: a 15-year population-based study
Source: Eur Respir J, 50 (1) 1700393; 10.1183/13993003.00393-2017
Year: 2017
Psychiatric disorders in patients with COPD: a population-based study on prevalence and the relationship with smoking
Source: Eur Respir J 2001; 18: Suppl. 33, 192s
Year: 2001
Sarcoidosis and subsequent cancer risk: a Danish nationwide cohort study
Source: Eur Respir J 2015; 45: 269-272
Year: 2015
Diabetic status and the risk of tuberculosis: a nationwide population-based study
Source: Virtual Congress 2020 – Tuberculosis: part 1
Year: 2020
Increased mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study
Source: Eur Respir J, 54 (5) 1900804; 10.1183/13993003.00804-2019
Year: 2019
Type 2 diabetes mellitus risk associated with sarcoidosis: A Swedish population-based cohort study
Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology
Year: 2020
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study
Source: Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020
Year: 2021
Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden
Source: Eur Respir J 2016; 48: 1690-1699
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept